Cantitate/Preț
Produs
Total produse
Vezi coșul
Progress in Bladder Cancer Research de A M Mallory

Progress in Bladder Cancer Research

Editat de A M Mallory
en Limba Engleză Hardback – 20 iun 2005
Bladder cancer is the fourth most common type of cancer in men and the eighth most common in women. This book includes within its scope the prevention, risk factors, symptoms, diagnosis, treatment, and rehabilitation of bladder cancer. Leading-edge scientific research from throughout the world is presented.
Citește tot Restrânge

Preț: 96546 lei

Preț vechi: 131823 lei
-27% Nou

Puncte Express: 1448
Preț estimativ în valută:
18477€ • 19249$ • 15362£

Carte disponibilă

Livrare economică 21 ianuarie-04 februarie 25

 Adaugă în coș

Wish list
Gift list
Am citit!
Adaugă în listă
Preluare comenzi: 021 569.72.76

Specificații

ISBN-13: 9781594541292
ISBN-10: 1594541299
Pagini: 238
Ilustrații: tables & charts
Dimensiuni: 260 x 180 x 25 mm
Greutate: 0.77 kg
Editura: Nova Science Publishers Inc
Colecția Nova Science Publishers, Inc (US)

Cuprins

Primary Adenocarcinoma of the Bladder: Distinction From Secondary Colorectal Adenocarcinoma; Angiogenesis and Bladder Cancer Role of Vascular Endothelial Growth Factor; Prognostic Factors Related to Survival, Recurrence and Progression of T1 Stage Bladder Transitional Cell Carcinoma: Importance of P53 and Ki67 Immunohistochemical Expression; The KAI1 Metastasis Suppresser in Bladder Cancer; Expression of Peroxisome Proliferator-Activated Receptors in Human Bladder Cancer Cell Lines and Correlation with Tumorigenicity and Malignancy; BCG Vaccination, Autoimmunity and Bladder Cancer; Evaluation of the BTA-TRAK Assay, Urinary Cytology, Sediment and their Combinations in the Follow-Up of Superficial Bladder Cancer; A Trial of Practical Computer Analysis of Urothelial Nuclei for Cancer Detection; Quadruple Cancer, Including Bladder Cancer and Triple Cancers in the Head and Neck Region; Advanced Transitional Cell Carcinoma of the Urothelium: Do We Have Treatment Options for Poor Prognosis Patients; Clinical Trials in High-Risk Superficial Bladder Cancer: News from the Beginning of Third Millennium.